The role of antimicrobial therapy in acute exacerbations of chronic bronchitis

American Journal of the Medical Sciences

Volumn 318, Issue 2, 1999, Pages 84-88

  Campbell Jr , G Douglas ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Acute exacerbations of chronic bronchitis (AECB); Antimicrobial resistance; Antimicrobial therapy; Protected specimen brush

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; CHRONIC BRONCHITIS; CONFERENCE PAPER; DRUG CHOICE; HUMAN; IMMUNE RESPONSE; TREATMENT OUTCOME;

EID: 0343183948     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199908000-00004     Document Type: Conference Paper

References (21)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44.
2. Silvennan EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-8.
3. Anthonisen NR, Manfreda J, Warren W, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
4. Ball P, Harris JM, Lowson D, et al. Acute infective exacerbations of chronic bronchitis. Q J Med 1995;88:61-8.
5. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995;108(2 Suppl):43S-52S.
6. Anonymous. Antibiotics for exacerbations of chronic bronchitis [editorial]. Lancet 1987;2:23-4.
7. Ball P, Tillotson G, Wilson R. Chemotherapy for chronic bronchitis. Controversies. Presse Med 1995;24:189-94.
8. Monso E, Ruiz J, Roselll A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20.
9. Fagon J, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990;142:1004-08.
10. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505.
11. Eller J, Ede A, Rosseutscher R, et al. Sputum bacteriology of acute infective exacerbations: COPD vs bronchiectasis. Eur Respir J 1996;9(Suppl. 23):107.
12. Musher DM, Kubitschek KR, Crennan J, et al. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 1983;99:444-50.
13. Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273:957-60.
14. Allegra L, Grasi C, Grossi E. The role of antibiotics in the treatment of chronic bronchitis exacerbations: follow-up of a multicenter study. Ital J Dis Chest 1991;45:138-45.
15. Wilson R. The role of infection in COPD. Chest 1998;113:242S-248S.
16. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
17. Baiter MS, Haland RH, Low DE, et al. Recommendations on the management of chronic bronchitis. Can Med Assoc J 1994;151(Suppl 10):5-23.
18. Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41:292-7.
19. Doern GV, Brueggemann AB, Pierce G, et al. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:2884-6.
20. Campbell Jr GD, Silberman R. Drug-resistant Streptococcus pneumonias. Clin Infect Dis 1998;26:1188-95.
21. Chodosh S. Treatment of acute exacerbations of chronic bronchitis: state of the art. Am J Med 1991;91(Supp 6A):87S-92S.